Soleno Therapeutics (SLNO) had the highest return between August 7, 2023 and October 30, 2023 by a mid-cap US stock, returning 393.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Soleno Therapeutics (SLNO) | 8/7/2023 - 10/30/2023 | 393.6% |
Apellis Pharmaceuticals (APLS) | 8/7/2023 - 10/30/2023 | 133.71% |
Belite Bio Inc ADR (BLTE) | 8/7/2023 - 10/30/2023 | 60.26% |
Scholar Rock (SRRK) | 8/7/2023 - 10/30/2023 | 57.88% |
Crinetics Pharmaceuticals (CRNX) | 8/7/2023 - 10/30/2023 | 56.76% |
Uranium Energy (UEC) | 8/7/2023 - 10/30/2023 | 55.86% |
Abercrombie & Fitch (ANF) | 8/7/2023 - 10/30/2023 | 50.95% |
Immunovant (IMVT) | 8/7/2023 - 10/30/2023 | 48.15% |
HUTCHMED DRC (HCM) | 8/7/2023 - 10/30/2023 | 42.36% |
Stride (LRN) | 8/7/2023 - 10/30/2023 | 40.92% |
United States Steel (X) | 8/7/2023 - 10/30/2023 | 40.02% |
Biohaven Pharmaceutical (BHVN) | 8/7/2023 - 10/30/2023 | 33.16% |
Paymentus (PAY) | 8/7/2023 - 10/30/2023 | 33.09% |
Frontline (FRO) | 8/7/2023 - 10/30/2023 | 31.74% |
Miniso Group Holding (MNSO) | 8/7/2023 - 10/30/2023 | 28.97% |
USA Compression Partners (USAC) | 8/7/2023 - 10/30/2023 | 26.79% |
Inter & Co Inc Class A Common Shares (INTR) | 8/7/2023 - 10/30/2023 | 25.92% |
United States Cellular (USM) | 8/7/2023 - 10/30/2023 | 25.7% |
Super (SGHC) | 8/7/2023 - 10/30/2023 | 25.41% |
Dlocal (DLO) | 8/7/2023 - 10/30/2023 | 23.51% |
Hafnia (HAFN) | 8/7/2023 - 10/30/2023 | 23.35% |
Telephone and Data Systems (TDS) | 8/7/2023 - 10/30/2023 | 23.3% |
Fabrinet (FN) | 8/7/2023 - 10/30/2023 | 22.08% |
H&R Block (HRB) | 8/7/2023 - 10/30/2023 | 21.82% |
Permian Resources (PR) | 8/7/2023 - 10/30/2023 | 21.04% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
